CRSP NASDAQ
CRISPR Therapeutics AG
1W: -1.1%
1M: -11.6%
3M: -6.7%
YTD: -7.2%
1Y: +27.1%
3Y: -19.1%
5Y: -53.2%
$50.36
+0.46 (+0.92%)
Weekly Expected Move ±9.2%
$40
$44
$48
$53
$57
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-02-12
EPS
$-1.37
▼ Miss -19.1%
Revenue
$864K
▼ Miss -81.7%
Next Earnings
2026-08-10
EPS Estimate
$-1.17
Range: $-1.37 - $-0.85
Revenue Estimate
$7M
14 analysts
Estimate vs Actual
Earnings Surprise History
12/18
EPS Beats
5/18
Revenue Beats
67%
EPS Beat Rate
28%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | annual | 2026-12-31 | $-4.84 | $-4.83 | ▲ 0.01 | $44,991,600 | $43,191,936 |
| 2026-05-15 | annual | 2030-12-31 | $15.66 | $14.12 | ▼ 1.54 | $4,681,243,245 | $4,323,722,975 |
| 2026-05-15 | annual | 2029-12-31 | $2.20 | $2.28 | ▲ 0.08 | $1,749,690,067 | $1,755,184,100 |
| 2026-05-15 | annual | 2028-12-31 | $-2.46 | $-2.41 | ▲ 0.05 | $509,669,859 | $511,880,378 |
| 2026-05-15 | annual | 2027-12-31 | $-3.83 | $-3.83 | — | $137,691,233 | $136,780,470 |
| 2026-05-13 | quarter | 2026-12-31 | $-1.16 | $-1.19 | ▼ 0.03 | $21,871,794 | $17,814,052 |
| 2026-05-13 | quarter | 2026-09-30 | $-1.17 | $-1.17 | — | $17,031,924 | $14,686,216 |
| 2026-05-13 | annual | 2030-12-31 | $19.15 | $15.66 | ▼ 3.49 | $4,978,499,270 | $4,681,243,245 |
| 2026-05-13 | quarter | 2027-03-31 | $-0.86 | $-0.87 | ▼ 0.01 | $37,997,000 | $22,036,000 |
| 2026-05-13 | quarter | 2027-06-30 | $-0.85 | $-0.79 | ▲ 0.06 | $39,505,250 | $26,817,286 |
| 2026-05-13 | quarter | 2027-09-30 | $-0.80 | $-0.76 | ▲ 0.04 | $44,357,750 | $30,461,571 |
| 2026-05-13 | quarter | 2027-12-31 | $-0.82 | $-0.75 | ▲ 0.07 | $44,765,750 | $32,994,714 |
| 2026-05-13 | quarter | 2026-06-30 | $-1.21 | $-1.17 | ▲ 0.04 | $8,253,829 | $7,092,680 |
| 2026-05-13 | annual | 2027-12-31 | $-3.72 | $-3.83 | ▼ 0.11 | $149,315,148 | $137,691,233 |
| 2026-05-13 | annual | 2026-12-31 | $-4.85 | $-4.84 | ▲ 0.01 | $47,978,406 | $44,991,600 |
Earnings Call Transcripts
No transcripts available.